Back to top
more

ResMed (RMD)

(Delayed Data from NYSE)

$272.60 USD

272.60
840,837

+1.41 (0.52%)

Updated Sep 16, 2025 03:59 PM ET

After-Market: $272.60 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (100 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

ResMed (RMD) Beats Earnings and Revenue Estimates in Q2

by Zacks Equity Research

ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.

    Zacks Equity Research

    Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD

    by Zacks Equity Research

    Medical is one of the broader sectors among the 16 Zacks sectors that is expected to report earnings growth in the fourth quarter.

      Zacks Equity Research

      ResMed (RMD) Q2 Earnings: Disappointment in the Cards?

      by Zacks Equity Research

      ResMed Inc. (RMD) is slated to report second-quarter fiscal 2017 results, after market close on Jan 23.

        Zacks Equity Research

        ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders

        by Zacks Equity Research

        ResMed Inc. (RMD) recently formed a joint venture with renowned surgeon and television host Dr. Mehmet Oz and private equity firm Pegasus Capital Advisors, L.P.

          Zacks Equity Research

          ResMed Achieves Key Milestone in Sleep-Disordered Breathing

          by Zacks Equity Research

          After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.

            Zacks Equity Research

            ResMed: SDB Business Faces Risks, Reimbursement a Drag

            by Zacks Equity Research

            On Dec 27, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).

              Kevin Matras headshot

              Using the Short Ratio to Forecast Turning Points

              by Kevin Matras

              Kevin Matras looks at the 'short ratio' as a market sentiment indicator and shows how to use it for finding winning stocks. Highlighted stocks include CRI, GTLS, RMD, VPRT and WWAV.